Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > the podcast says it was released today.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12061)
•••
Comment by ScienceFirston Nov 17, 2022 7:31pm
106 Views
Post# 35108949

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:the podcast says it was released today.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:the podcast says it was released today.Boring GranhamB ...  The boring accountant that lives in the past (SEDAR)


Now he's FUDing that with 30 sales reps + soon up to 10 regional distributors, sales in 2023 won't be at the rendez-vous and the more sales, the closer a buy out!

- The guy silence anything in the future.
- What he raises about expenses is no different than any other players like GEHC, etc ....  Sales come with expenses.  We all know that.  Margins in this field are above 0.  Usually above 40+%.

_______________________

“We continue to project cumulative users and sales at 40-45 sites by year end”

 

How many sales vs free placements ?

 

What is the cost of all this ? If there are 30+ salespeople that is less than 1 sale per person

What is the added cost of all these distributors and sales people and conferences vs sales

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities